Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eleven analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $129.33.
ADUS has been the subject of several analyst reports. Royal Bank Of Canada raised their target price on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Raymond James Financial set a $137.00 price target on Addus HomeCare in a research report on Monday, September 28th. Weiss Ratings upgraded Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, September 24th. Citigroup downgraded shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a report on Monday, September 14th. Finally, Barclays raised their price objective on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research report on Wednesday, July 8th.
Check Out Our Latest Stock Analysis on Addus HomeCare
Institutional Trading of Addus HomeCare
Addus HomeCare Trading Down 0.7%
NASDAQ:ADUS opened at $115.16 on Tuesday. The company has a market cap of $2.15 billion, a P/E ratio of 20.20, a P/E/G ratio of 1.65 and a beta of 0.83. The stock’s fifty day moving average price is $116.32 and its two-hundred day moving average price is $105.68. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $124.43. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. The firm had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period last year, the company earned $1.49 earnings per share. As a group, analysts expect that Addus HomeCare will post 6.33 EPS for the current year.
About Addus HomeCare
Addus HomeCare Corporation is a provider of home-based health care and support services for older adults, people with disabilities and other individuals who require assistance at home. The company’s services are designed to help clients maintain independence and avoid or delay institutional care.
Addus operates through three primary service lines: personal care, home health and hospice. Personal care services include assistance with daily activities such as bathing, dressing, meal preparation and mobility.
See Also
- Five stocks we like better than Addus HomeCare
- D-Wave Stock Has 2 New Reasons for Investors to Pay Attention
- Amprius Technologies’ Next Big Rally Could Be Taking Shape
- 4 Stocks With Demand So Sticky That the AI Sell-Off Barely Touched Them at All
- Tesla’s Roadster Reveal Hints at 2 Much Bigger Moves
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
